Narwhal Capital Management
Source: SEC Form 13F · as of Mar 2026Narwhal Capital Management holds 10 biotech & pharma companies tracked by BioSniper, totaling $84.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$84.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 94,611 | $23.1M |
| LLYELI LILLY & Co | 21,484 | $19.8M |
| MRKMerck & Co., Inc. | 111,375 | $13.4M |
| PMPhilip Morris International Inc | 63,896 | $10.6M |
| NVSNovartis AG | 52,668 | $8.0M |
| ABTABBOTT LABORATORIES | 71,812 | $7.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,554 | $1.2M |
| ELVElevance Health Inc. | 1,478 | $433K |
| AMGNAMGEN INC | 1,017 | $358K |
| FATEFATE THERAPEUTICS INC | 12,700 | $15K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.